Microbiome NewsA recent study published in Cell investigates the role of osteopontin (OPN), a protein found in breast milk, in shaping the infant microbiome and immune system. The research provides new insights into how breastfeeding may protect against severe lower respiratory infections (sLRIs) in infants, a leading cause of infant mortality. The study focuses on the interactions between milk-derived OPN, the microbiome, and immune development in neonatal mice.
The Role of Osteopontin in Immune Development
Osteopontin is highly expressed in colostrum, the first form of milk produced after birth. The study demonstrates that the absence of OPN in milk predisposes neonatal mice to viral and bacterial sLRIs. This increased susceptibility is linked to disruptions in dendritic cell (DC) hematopoiesis, the process by which new blood cells are formed, in the developing liver and lung. These findings suggest that OPN plays a crucial role in the early development of the immune system.
In the study, researchers supplemented neonatal mice with oral OPN, which resulted in a reduction in disease severity. This amelioration was associated with an increased abundance of Lactobacillaceae in the gut and elevated levels of serum 3-phenyllactic acid (PLA). PLA acts as an agonist for the peroxisome proliferator-activated receptor gamma (PPARγ), a protein that regulates gene expression and plays a role in immune responses.
Microbiome-Host Interactions
The study highlights the complex interactions between the microbiome and host immune development. Supplementation with PLA or the PPARγ agonist rosiglitazone was shown to restore lung DC hematopoiesis. This process involved the recruitment of lymphoid-myeloid primed progenitors and the induction of a supportive lung niche, mediated by the chemokine ligand 25 (CCL25) derived from the airway epithelium.
However, the protective effects of PLA-induced DC hematopoiesis and disease tolerance were reduced when plasmacytoid DCs were depleted, stem cell factor was neutralized, or the airway epithelial Flt3L gene was deleted. These findings suggest that multiple components of the immune system and microbiome are involved in the protective mechanisms conferred by milk OPN.
Implications and Limitations
This study provides valuable insights into the potential mechanisms by which breastfeeding may confer protection against infections in infants. By elucidating the role of OPN in microbiome-host interactions and immune development, the research highlights the importance of early nutritional and microbial exposures in shaping the immune system.
However, there are limitations to this study. The research was conducted in neonatal mice, and while these findings provide a basis for understanding similar processes in humans, further research is needed to confirm these mechanisms in human infants. Additionally, the study focuses on associations rather than direct causation, and more work is required to fully understand the pathways involved.
For those interested in the broader implications of microbiome research, our explainer on Akkermansia muciniphila offers insights into another important member of the gut microbiome.
Frequently asked
What is osteopontin?
Osteopontin is a protein found in high concentrations in colostrum, the first form of breast milk produced after birth. It plays a role in immune development and has been linked to the protection against infections in infants.
How does osteopontin affect the infant microbiome?
The study found that osteopontin influences the infant microbiome by increasing the abundance of Lactobacillaceae in the gut. This change is associated with improved immune responses and reduced severity of infections in neonatal mice.
What are the limitations of this study?
The study was conducted in neonatal mice, which may not fully replicate human biology. Additionally, the findings are based on associations, and further research is needed to confirm these mechanisms in humans.